AstraZeneca invests $2.5bn to build new R&D centre in Beijing, China
|
The investment, part of a strategic partnership with the Beijing
Municipal Government and the Beijing Economic-Technological
Development Area ... |
UBS lowers forecast for China 2025 GDP growth to 3.4% on tariff hikes
UBS has downgraded its China GDP growth forecast to 3.4% for 2025, on the assumption that tariff hikes between it and the United States will ... View article...